SciSparc Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024 - Marketscreener.com
SPRC Stock | USD 0.22 0.01 4.76% |
About 55% of Scisparc's shareholders are presently thinking to get in. The analysis of the overall investor sentiment regarding Scisparc suggests that some traders are interested. The current market sentiment, together with Scisparc's historical and current headlines, can help investors time the market. In addition, many technical investors use Scisparc stock news signals to limit their universe of possible portfolio assets.
Scisparc |
SciSparc Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024 Marketscreener.com
Read at news.google.com
Scisparc Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Scisparc can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Scisparc Fundamental Analysis
We analyze Scisparc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Scisparc using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Scisparc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Retained Earnings
Retained Earnings Comparative Analysis
Scisparc is currently under evaluation in retained earnings category among its peers. Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.
Scisparc Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Scisparc stock to make a market-neutral strategy. Peer analysis of Scisparc could also be used in its relative valuation, which is a method of valuing Scisparc by comparing valuation metrics with similar companies.
Peers
Scisparc Related Equities
QNRX | Quoin Pharmaceuticals | 28.12 | ||||
CTMX | CytomX Therapeutics | 12.84 | ||||
HOTH | Hoth Therapeutics | 4.88 | ||||
KPRX | Kiora Pharmaceuticals | 0.29 | ||||
ASMB | Assembly Biosciences | 2.09 | ||||
TIL | Instil Bio | 2.86 | ||||
ZVSA | ZyVersa Therapeutics | 2.91 | ||||
NUVB | Nuvation Bio | 3.02 | ||||
CDIO | Cardio Diagnostics | 3.23 | ||||
UNCY | Unicycive Therapeutics | 4.05 | ||||
VRAX | Virax Biolabs | 4.62 | ||||
CVKD | Cadrenal Therapeutics, | 7.77 | ||||
REVB | Revelation Biosciences | 46.32 |
Complementary Tools for Scisparc Stock analysis
When running Scisparc's price analysis, check to measure Scisparc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Scisparc is operating at the current time. Most of Scisparc's value examination focuses on studying past and present price action to predict the probability of Scisparc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Scisparc's price. Additionally, you may evaluate how the addition of Scisparc to your portfolios can decrease your overall portfolio volatility.
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
CEOs Directory Screen CEOs from public companies around the world | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation |